87 related articles for article (PubMed ID: 4438822)
1. Phytomitogen and neuraminidase in the treatment of Ehrlich carcinoma in mice.
Mobley JR; Graber CD; O'Brien PH; Gale GR; Neeley B
Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):155-62. PubMed ID: 4438822
[No Abstract] [Full Text] [Related]
2. Inhibition of Ehrlich ascites tumor cell growth by Griffonia simplicifolia I lectin in vivo.
Eckhardt AE; Malone BN; Goldstein IJ
Cancer Res; 1982 Aug; 42(8):2977-9. PubMed ID: 7093946
[TBL] [Abstract][Full Text] [Related]
3. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
Sur P; Roy DK
Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
[No Abstract] [Full Text] [Related]
4. [Inhibition of tumor cell growth using lectin from the bean of Ricinus communis].
Gürtler L; Steinhoff D
Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1521. PubMed ID: 4649787
[No Abstract] [Full Text] [Related]
5. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
6. [Inhibiting effect of cholera vibrio neuraminidase in Rauscher mouse leukemia].
Barinskiĭ IF; Korbinskiĭ GD
Biull Eksp Biol Med; 1976; 82(11):1357-9. PubMed ID: 1016719
[TBL] [Abstract][Full Text] [Related]
7. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
[No Abstract] [Full Text] [Related]
8. [Ovarian cancer: treatment by specific neuraminidase].
Dodin A; Zylberberg B
Nouv Presse Med; 1979 Feb; 8(6):437. PubMed ID: 554105
[No Abstract] [Full Text] [Related]
9. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
Sedlacek HH; Johannsen R; Seiler FR
Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
[No Abstract] [Full Text] [Related]
10. [Effect of peplomycin by continuous infusion on Ehrlich carcinoma].
Kato T; Mizutani M; Ota K
Gan To Kagaku Ryoho; 1983 Mar; 10(3):763-7. PubMed ID: 6192767
[TBL] [Abstract][Full Text] [Related]
11. Neuraminidase immunotherapy of tumors in man.
Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
[No Abstract] [Full Text] [Related]
12. [The effect of single and combined treatments on Ehrlich ascites tumor in mice].
Mekori T; Robinson E
Harefuah; 1971 Feb; 80(3):123-5. PubMed ID: 4999821
[No Abstract] [Full Text] [Related]
13. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase.
Simmons RL; Rios A
Surgery; 1972 Apr; 71(4):556-64. PubMed ID: 5021071
[No Abstract] [Full Text] [Related]
14. Effect of local or distal therapeutic treatment with polyinosinic-polycytidylic acid on survival of mice with Ehrlich carcinoma.
DuBuy HG
J Natl Cancer Inst; 1972 May; 48(5):1525-7. PubMed ID: 5030961
[No Abstract] [Full Text] [Related]
15. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
Hartveit F; Halleraker B
J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
[No Abstract] [Full Text] [Related]
16. Antitumor activity in the culture supernatant fluid of Fusobacterium nucleatum strain KO-31.
Tamai K; Nakao J; Nakagawa K; Watanabe K; Sakashita H; Nishiwaki Y; Nakashin T
Jpn J Exp Med; 1983 Oct; 53(5):251-6. PubMed ID: 6433084
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
18. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
[No Abstract] [Full Text] [Related]
20. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
